News > RMMS Awarded Impact Case of the Year by LMG Life Sciences

RMMS Awarded Impact Case of the Year by LMG Life Sciences

09/18/2019

On September 18, 2019, RMMS was awarded Impact Case of the Year at the 2019 LMG Life Sciences Awards for the firm's work on the Teva Pharmaceuticals et al. v. Sandoz et al. (Copaxone) litigation.  The award recognizes RMMS contributions on behalf of its client, Sandoz, in connection with the 2016 trial win and subsequent 2019 Federal Circuit affirmance finding the asserted claims of four U.S. patents directed to methods of dosing glatiramer acetate 40mg/mL injection invalid as obvious.

Several members of the RMMS team were on hand for the awards ceremony, and members of the Copaxone team, including Deanne Mazzochi, Rachel Pernic Waldron, Matthew Anderson, Thomas Ehrich and Christopher Galligan, accepted the award on behalf of the firm.  

LMG Life Sciences is the definitive guide to leading North American law firms and lawyers specialized in the life sciences industry in four categories: Finance and Transactional; Regulatory; Intellectual Property and Non-IP Litigation and Enforcement. The LMG Life Sciences Awards are based on a weighted system of peer, client, and firm feedback recognizing firms, individuals, and companies behind the most innovative and challenging life sciences work from the past year, as well as those driving the market.